David A Sykes (David Sykes)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Molecular Dynamics Simulations

Structural Basis

Machine Learning

Top Venues

Research square

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

David E Gloriam, Thor Thorsen, Yashraj Kulkarni, David A Sykes, Andreas Bøggild, Taner Drace, Pattarin Hompluem, Christos Iliopoulos-Tsoutsouvas, Spyros P Nikas, Henrik Daver, Alexandros Makriyannis, Poul Nissen, Michael Gajhede, Dmitry B Veprintsev, Thomas Boesen, Jette Kastrup
Structural basis of Δ9-THC analog activity at the Cannabinoid 1 receptor. Research square (2024)
David E Gloriam, Thor Thorsen, Yashraj Kulkarni, David A Sykes, Andreas Bøggild, Taner Drace, Pattarin Hompluem, Christos Iliopoulos-Tsoutsouvas, Spyros P Nikas, Henrik Daver, Alexandros Makriyannis, Poul Nissen, Michael Gajhede, Dmitry B Veprintsev, Thomas Boesen, Jette Kastrup
Structural basis of Δ 9 -THC analog activity at the Cannabinoid 1 receptor. Research square (2024)
David E Gloriam, Thor Thorsen, Yashraj Kulkarni, David A Sykes, Andreas Bøggild, Taner Drace, Pattarin Hompluem, Christos Iliopoulos-Tsoutsouvas, Spyros P Nikas, Henrik Daver, Alexandros Makriyannis, Poul Nissen, Michael Gajhede, Dmitry B Veprintsev, Thomas Boesen, Jette Kastrup
Structural basis of Δ9-THC analog activity at the Cannabinoid 1 receptor. Research square (2024)
Mireia Jiménez-Rosés, Bradley Angus Morgan, Maria Jimenez Sigstad, Thuy Duong Zoe Tran, Rohini Srivastava, Asuman Bunsuz, Leire Borrega-Román, Pattarin Hompluem, Sean A Cullum, Clare R Harwood, Eline J Koers, David A Sykes, Iain B Styles, Dmitry B Veprintsev
Combined docking and machine learning identify key molecular determinants of ligand pharmacological activity on β2 adrenoceptor. Pharmacology research & perspectives 10 (5) (2022)
David A Sykes, Mireia Jiménez-Rosés, John Reilly, Robin A Fairhurst, Steven J Charlton, Dmitry B Veprintsev
Exploring the kinetic selectivity of drugs targeting the β 1 -adrenoceptor. Pharmacology research & perspectives 10 (4) (2022)